Mercy Kanyuka1, Jameson Ndawala1, Tiope Mleme1, Lusungu Chisesa1, Medson Makwemba1, Agbessi Amouzou2, Josephine Borghi3, Judith Daire4, Rufus Ferrabee5, Elizabeth Hazel6, Rebecca Heidkamp6, Kenneth Hill6, Melisa Martínez Álvarez3, Leslie Mgalula7, Spy Munthali8, Bejoy Nambiar9, Humphreys Nsona10, Lois Park6, Neff Walker6, Bernadette Daelmans7, Jennifer Bryce6, Tim Colbourn11. 1. Malawi National Statistics Office, Zomba, Malawi. 2. Data and Analytics, UNICEF, New York, NY, USA. 3. Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK. 4. Malawi College of Medicine, Blantyre, Malawi. 5. University College London, Institute for Global Health, London, UK; Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland. 6. Institute for International Programs, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland. 8. Chancellor College, University of Malawi, Zomba, Malawi. 9. University College London, Institute for Global Health, London, UK. 10. Malawi Ministry of Health (IMCI), Lilongwe, Malawi. 11. University College London, Institute for Global Health, London, UK. Electronic address: t.colbourn@ucl.ac.uk.
Abstract
BACKGROUND: Several years in advance of the 2015 endpoint for the Millennium Development Goals (MDGs), Malawi was already thought to be one of the few countries in sub-Saharan Africa likely to meet the MDG 4 target of reducing under-5 mortality by two-thirds between 1990 and 2015. Countdown to 2015 therefore selected the Malawi National Statistical Office to lead an in-depth country case study, aimed mainly at explaining the country's success in improving child survival. METHODS: We estimated child and neonatal mortality for the years 2000-14 using five district-representative household surveys. The study included recalculation of coverage indicators for that period, and used the Lives Saved Tool (LiST) to attribute the child lives saved in the years from 2000 to 2013 to various interventions. We documented the adoption and implementation of policies and programmes affecting the health of women and children, and developed estimates of financing. FINDINGS: The estimated mortality rate in children younger than 5 years declined substantially in the study period, from 247 deaths (90% CI 234-262) per 1000 livebirths in 1990 to 71 deaths (58-83) in 2013, with an annual rate of decline of 5·4%. The most rapid mortality decline occurred in the 1-59 months age group; neonatal mortality declined more slowly (from 50 to 23 deaths per 1000 livebirths), representing an annual rate of decline of 3·3%. Nearly half of the coverage indicators have increased by more than 20 percentage points between 2000 and 2014. Results from the LiST analysis show that about 280,000 children's lives were saved between 2000 and 2013, attributable to interventions including treatment for diarrhoea, pneumonia, and malaria (23%), insecticide-treated bednets (20%), vaccines (17%), reductions in wasting (11%) and stunting (9%), facility birth care (7%), and prevention and treatment of HIV (7%). The amount of funding allocated to the health sector has increased substantially, particularly to child health and HIV and from external sources, but remains below internationally agreed targets. Key policies to address the major causes of child mortality and deliver high-impact interventions at scale throughout Malawi began in the late 1990s and intensified in the latter half of the 2000s and into the 2010s, backed by health-sector-wide policies to improve women's and children's health. INTERPRETATION: This case study confirmed that Malawi had achieved MDG 4 for child survival by 2013. Our findings suggest that this was achieved mainly through the scale-up of interventions that are effective against the major causes of child deaths (malaria, pneumonia, and diarrhoea), programmes to reduce child undernutrition and mother-to-child transmission of HIV, and some improvements in the quality of care provided around birth. The Government of Malawi was among the first in sub-Saharan Africa to adopt evidence-based policies and implement programmes at scale to prevent unnecessary child deaths. Much remains to be done, building on this success and extending it to higher proportions of the population and targeting continued high neonatal mortality rates. FUNDING: Bill & Melinda Gates Foundation, WHO, The World Bank, Government of Australia, Government of Canada, Government of Norway, Government of Sweden, Government of the UK, and UNICEF.
BACKGROUND: Several years in advance of the 2015 endpoint for the Millennium Development Goals (MDGs), Malawi was already thought to be one of the few countries in sub-Saharan Africa likely to meet the MDG 4 target of reducing under-5 mortality by two-thirds between 1990 and 2015. Countdown to 2015 therefore selected the Malawi National Statistical Office to lead an in-depth country case study, aimed mainly at explaining the country's success in improving child survival. METHODS: We estimated child and neonatal mortality for the years 2000-14 using five district-representative household surveys. The study included recalculation of coverage indicators for that period, and used the Lives Saved Tool (LiST) to attribute the child lives saved in the years from 2000 to 2013 to various interventions. We documented the adoption and implementation of policies and programmes affecting the health of women and children, and developed estimates of financing. FINDINGS: The estimated mortality rate in children younger than 5 years declined substantially in the study period, from 247 deaths (90% CI 234-262) per 1000 livebirths in 1990 to 71 deaths (58-83) in 2013, with an annual rate of decline of 5·4%. The most rapid mortality decline occurred in the 1-59 months age group; neonatal mortality declined more slowly (from 50 to 23 deaths per 1000 livebirths), representing an annual rate of decline of 3·3%. Nearly half of the coverage indicators have increased by more than 20 percentage points between 2000 and 2014. Results from the LiST analysis show that about 280,000 children's lives were saved between 2000 and 2013, attributable to interventions including treatment for diarrhoea, pneumonia, and malaria (23%), insecticide-treated bednets (20%), vaccines (17%), reductions in wasting (11%) and stunting (9%), facility birth care (7%), and prevention and treatment of HIV (7%). The amount of funding allocated to the health sector has increased substantially, particularly to child health and HIV and from external sources, but remains below internationally agreed targets. Key policies to address the major causes of child mortality and deliver high-impact interventions at scale throughout Malawi began in the late 1990s and intensified in the latter half of the 2000s and into the 2010s, backed by health-sector-wide policies to improve women's and children's health. INTERPRETATION: This case study confirmed that Malawi had achieved MDG 4 for child survival by 2013. Our findings suggest that this was achieved mainly through the scale-up of interventions that are effective against the major causes of child deaths (malaria, pneumonia, and diarrhoea), programmes to reduce child undernutrition and mother-to-child transmission of HIV, and some improvements in the quality of care provided around birth. The Government of Malawi was among the first in sub-Saharan Africa to adopt evidence-based policies and implement programmes at scale to prevent unnecessary child deaths. Much remains to be done, building on this success and extending it to higher proportions of the population and targeting continued high neonatal mortality rates. FUNDING: Bill & Melinda Gates Foundation, WHO, The World Bank, Government of Australia, Government of Canada, Government of Norway, Government of Sweden, Government of the UK, and UNICEF.
Authors: Miwako Kobayashi; Dyson Mwandama; Humphreys Nsona; Ruth J Namuyinga; Monica P Shah; Andrew Bauleni; Jodi Vanden Vanden Eng; Alexander K Rowe; Don P Mathanga; Laura C Steinhardt Journal: Am J Trop Med Hyg Date: 2017-05 Impact factor: 2.345
Authors: Patrick T McGann; Anne M Williams; Graham Ellis; Kathryn E McElhinney; Laurel Romano; Julia Woodall; Thad A Howard; Gerald Tegha; Robert Krysiak; R Murray Lark; E Louise Ander; Carine Mapango; Kenneth I Ataga; Satish Gopal; Nigel S Key; Russell E Ware; Parminder S Suchdev Journal: Blood Adv Date: 2018-11-13
Authors: Agbessi Amouzou; Mercy Kanyuka; Elizabeth Hazel; Rebecca Heidkamp; Andrew Marsh; Tiope Mleme; Spy Munthali; Lois Park; Benjamin Banda; Lawrence H Moulton; Robert E Black; Kenneth Hill; Jamie Perin; Cesar G Victora; Jennifer Bryce Journal: Am J Trop Med Hyg Date: 2016-01-19 Impact factor: 2.345
Authors: Carlyn Mann; Courtney Ng; Nadia Akseer; Zulfiqar A Bhutta; Josephine Borghi; Tim Colbourn; Patricia Hernández-Peña; Luis Huicho; Muhammad Ashar Malik; Melisa Martinez-Alvarez; Spy Munthali; Ahmad Shah Salehi; Mekonnen Tadesse; Mohammed Yassin; Peter Berman Journal: BMC Public Health Date: 2016-09-12 Impact factor: 3.295
Authors: Shams El Arifeen; Harry Campbell; Ahmed Ehsanur Rahamn; Shema Mhajabin; David Dockrell; Harish Nair Journal: BMC Health Serv Res Date: 2021-07-07 Impact factor: 2.655
Authors: Yvonne Tam; Luis Huicho; Carlos A Huayanay-Espinoza; María Clara Restrepo-Méndez Journal: BMC Public Health Date: 2016-10-04 Impact factor: 3.295